Related Experiment Video
Updated: Jun 13, 2026
10:52
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Peripheral T cell lymphoma: new model + new insight
1Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. james.mulloy@cchmc.org
The Journal of Experimental Medicine
|May 5, 2010
Summary
The spleen tyrosine kinase (SYK) is a key oncogene in blood cancers. A new peripheral T cell lymphoma model helps study SYK
Area of Science:
- Oncology
- Molecular Biology
- Hematology
Background:
- Nonreceptor tyrosine kinase SYK is recognized as a critical oncogene in hematologic malignancies.
- SYK plays a significant role in various blood cancers.
Purpose of the Study:
- To develop a novel model for studying peripheral T cell lymphoma (PTCL).
- To investigate the role of the ITK-SYK fusion gene in PTCL pathogenesis.
- To dissect signaling pathways implicated in SYK-associated malignancy within t(5;9) PTCL.
Main Methods:
- Development of a new animal model for PTCL.
- Utilizing the ITK-SYK fusion gene in the model.
- Analysis of signaling cascades in PTCL.
Main Results:
- A novel PTCL model incorporating the ITK-SYK fusion gene has been established.
- This model provides a platform for dissecting SYK-driven oncogenic signaling.
- The model is relevant for understanding t(5;9) PTCL.
Conclusions:
- The newly developed PTCL model is a valuable tool for researching SYK-associated malignancies.
- Understanding SYK signaling is crucial for therapeutic strategies in PTCL.
- This model facilitates the study of specific genetic alterations in PTCL.
